Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study

NCT04398368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Focus research efforts on other projects.

Conditions

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
Stage 0a Renal Pelvis Cancer AJCC v8
Stage 0a Ureter Cancer AJCC v8
Stage 0is Renal Pelvis and Ureter Cancer AJCC v8
Stage 0is Renal Pelvis Cancer AJCC v8
Stage 0is Ureter Cancer AJCC v8
Stage I Renal Pelvis and Ureter Cancer AJCC v8
Stage I Renal Pelvis Cancer AJCC v8
Stage I Ureter Cancer AJCC v8
Stage II Renal Pelvis and Ureter Cancer AJCC v8
Stage II Renal Pelvis Cancer AJCC v8
Stage II Ureter Cancer AJCC v8
Stage III Renal Pelvis and Ureter Cancer AJCC v8
Stage III Renal Pelvis Cancer AJCC v8
Stage III Ureter Cancer AJCC v8
Stage IV Renal Pelvis and Ureter Cancer AJCC v8
Stage IV Renal Pelvis Cancer AJCC v8
Stage IV Ureter Cancer AJCC v8

Interventions

DRUG: Gemcitabine Hydrochloride

Sponsor

Mayo Clinic